Researching for genetic sequences has come a long way in the past 25 years. There are large public databases that contain a wealth of information however they make up a fraction of the data when combined with proprietary databases, in-house databases, images, illustations, local hard drive data and print documents.

The lack of complete data can cost biotechnology and pharmaceutical companies millions of dollars a year in wasted resources on incomplete, out-of-date or unusable sequence data. This data can lead to:

Read the rest of this entry »